Elevated serum bilirubin levels are associated with improved survival in patients with curatively resected non-small-cell lung cancer

Moderately elevated pretreatment bilirubin levels are associated with longer OS, DFS, and DMFS for patients with curatively resected NSCLC. IBIL is an independent prognostic factor in curative resected NSCLC.